[DDN Review] Antibody Combination Approach to Target Allergies at the Source: Drug Discovery News Summary (With My Thoughts)
A U.S. research team is developing a novel combination therapy of antibody drugs that directly targets the underlying causes of allergic diseases. The strategy simultaneously blocks immunoglobulin E (IgE), a key driver of allergic reacti...
